BioSpace News Archive

The Lubrizol Corporation announced that Mary Rhinehart will serve as president and CEO on an interim basis, effective immediately.

AnPac Bio-Medical Science Co., Ltd. announced that on March 8, 2022, it received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC indicating that the Company is not in compliance with the minimum bid price requirement of US$1.00 per share under the Nasdaq Listing Rules.

Cipher Pharmaceuticals Inc. announced that it will release its financial and operating results for the three and twelve months ended December 31, 2021 after market close on March 17, 2022.

Helix BioPharma Corp. announces that it has closed a private placement financing for gross proceeds of $1,001,000 from the issuance of 3,850,000 common share at a price of $0.26 per common share.

ERYTECH Pharma,a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, provided a business update and an update on its cash position at the end of December 2021.

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced the U.S. Food and Drug Administration has approved Myriad’s BRACAnalysis® CDx test for use as a companion diagnostic to identify patients with germline BRCA-mutated HER2 negative, high-risk early-stage breast cancer who may benefit from Lynparza®.

AstraZeneca and Merck, known as MSD outside the United States and Canada, announced that LYNPARZA has been approved by the U.S. Food and Drug Administration for the adjuvant treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated, human epidermal growth factor receptor 2 -negative high-risk early breast cancer who have been treated with neoadjuvant or adjuvant chemotherapy.

Orexo AB, announces that the company has appointed Fredrik Järrsten as new Chief Financial Officer and a member of the management team, starting at latest in early September, 2022.

Amsterdam, the Netherlands – Royal Philips, a global leader in health technology, announced that Collaboration Live has received expansion of its U.S. Food & Drug Administration 510 market clearance for remote diagnostic use on additional mobile platforms.

HUTCHMED Limited would like to provide an update on its status under the Holding Foreign Companies Accountable Act.